In 2026, fast and agile development isn’t a competitive advantage for medical device companies — it’s the baseline for innovation. The methods the industry relied on two decades ago simply can’t keep pace with today’s demands.

Regulatory timelines aren’t killing progress, and manufacturing constraints aren’t the real bottleneck. The biggest threat to innovation is delayed decision-making, late‑stage changes, and failing to consider end-user adoption early in development.

In this insight talk, Samuel Guest, Global Product Manager at Protolabs, explores how leading MedTech teams navigate these pressures by building operational agility into their development programmes. He will unpack why rapid iteration of critical components — while not inexpensive — is essential for early design validation, smoother V&V, and avoiding late‑stage redesigns that delay approval. He will also explore how treating failure as a learning moment can improve decisions, streamline processes, accelerate development, and support smoother adoption across end-user environments.

Digital manufacturing accelerates the path from prototype to production, but its greatest value comes from engaging manufacturing partners early. With production expertise involved from the start, MedTech teams can anticipate challenges, reduce risk, and move forward with greater confidence